Detection of Infantile Batten Disease by Tandem Mass Spectrometry Assay of PPT1 Enzyme Activity in Dried Blood Spots.
Hamid KhalediYang LiuSophia MasiMichael H GelbPublished in: Analytical chemistry (2018)
A new tandem mass spectrometry (MS/MS)-based approach for measurement of the enzymatic activity of palmitoyl protein thioesterase I (PPT1) in dried blood spots (DBS) is presented. Deficiency in this enzyme leads to infantile neuronal ceroid lipofuscinosis (INCL, Infantile Batten disease, CLN1). The assay could distinguish between 80 healthy newborns and three previously diagnosed INCL patients. Unlike the fluorimetric PPT1 assay, the MS/MS assay does not require recombinant β-glucosidase. Furthermore, the assay could be easily combined with a TPP1 enzyme assay (for CLN2 disease) and can be potentially multiplexed with a large panel of additional lysosomal enzyme assays by MS/MS for newborn screening and postscreening analysis.
Keyphrases
- tandem mass spectrometry
- high throughput
- ms ms
- ultra high performance liquid chromatography
- high performance liquid chromatography
- simultaneous determination
- liquid chromatography
- gas chromatography
- liquid chromatography tandem mass spectrometry
- mass spectrometry
- solid phase extraction
- high resolution
- ejection fraction
- end stage renal disease
- newly diagnosed
- brain injury
- deep brain stimulation
- small molecule
- subarachnoid hemorrhage
- quantum dots
- peritoneal dialysis
- protein protein